Shopping Cart
- Remove All
- Your shopping cart is currently empty
Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $297 | In Stock | |
5 mg | $649 | In Stock | |
10 mg | $891 | In Stock | |
25 mg | $1,350 | In Stock | |
50 mg | $1,820 | In Stock |
Description | Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma. |
Molecular Weight | 145.21 kDa |
Cas No. | 2088770-90-3 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.